Financial reports
10-Q
2020 Q3
Quarterly report
9 Nov 20
10-Q
2020 Q2
Quarterly report
10 Aug 20
10-Q
2020 Q1
Quarterly report
11 May 20
10-K
2019 FY
Annual report
16 Mar 20
10-Q
2019 Q3
Quarterly report
12 Nov 19
10-Q
2019 Q2
Quarterly report
9 Aug 19
10-Q
2019 Q1
Quarterly report
10 May 19
10-K
2018 FY
Annual report
2 Apr 19
NT 10-K
Notice of late annual filing
18 Mar 19
10-Q
2018 Q3
Quarterly report
9 Nov 18
Current reports
8-K
BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals
2 Dec 20
8-K
BioSpecifics Reports Third Quarter 2020 Financial and Operating Results
9 Nov 20
8-K
BioSpecifics to be Acquired by Endo Pharmaceuticals
19 Oct 20
8-K
Regulation FD Disclosure
14 Sep 20
8-K
Entry into a Material Definitive Agreement
31 Aug 20
8-K
Regulation FD Disclosure
11 Aug 20
8-K
BioSpecifics Reports Second Quarter 2020 Financial and Operating Results
10 Aug 20
8-K
BioSpecifics Appoints Alex Monteith as Chief Business Officer
20 Jul 20
8-K
Regulation FD Disclosure
14 Jul 20
8-K
Amendments to Articles of Incorporation or Bylaws
15 Jun 20
Registration and prospectus
15-12B
Securities registration termination
22 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Dec 20
RW
Registration withdrawal request
2 Dec 20
SC 14D9/A
Tender offer solicitation (amended)
2 Dec 20
SC TO-T/A
Third party tender offer statement (amended)
2 Dec 20
25-NSE
Exchange delisting
2 Dec 20
SC 14D9/A
Tender offer solicitation (amended)
23 Nov 20
Proxies
DEF 14A
Definitive proxy
29 Apr 20
PRE 14A
Preliminary proxy
17 Apr 20
DEFA14A
Additional proxy soliciting materials
31 May 19
DEFA14A
Additional proxy soliciting materials
3 May 19
DEF 14A
Definitive proxy
30 Apr 19
DEF 14A
Definitive proxy
30 Apr 18
DEF 14A
Definitive proxy
28 Apr 17
DEF 14A
Definitive proxy
29 Apr 16
DEF 14A
Definitive proxy
29 Apr 15
DEFR14A
Revised proxy
7 May 14
Other
EFFECT
Notice of effectiveness
20 Jul 20
CORRESP
Correspondence with SEC
15 Jul 20
UPLOAD
Letter from SEC
30 Jun 20
UPLOAD
Letter from SEC
20 Apr 20
CT ORDER
Confidential treatment order
5 Apr 16
UPLOAD
Letter from SEC
28 Oct 14
CORRESP
Correspondence with SEC
23 Oct 14
UPLOAD
Letter from SEC
20 Oct 14
CORRESP
Correspondence with SEC
22 Aug 14
UPLOAD
Letter from SEC
15 Aug 14
Ownership
SC 13G/A
RICE HALL JAMES & ASSOCIATES, LLC
16 Feb 21
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
10 Feb 21
4
Change in insider ownership
8 Dec 20
SC 13D/A
Endo International plc
4 Dec 20
4
Jennifer M Chao
2 Dec 20
4
Toby Wegman
2 Dec 20
4
Corey N. Fishman
2 Dec 20
4
Mark N Wegman
2 Dec 20
4
Michael Schamroth
2 Dec 20
4
Joseph Truitt
2 Dec 20